Deal snapshot: Catabasis Pharmaceuticals Acquires Quellis Biosciences in Stock Transaction.

MANews-(C)2009-2021

Boston, US-based biopharmaceutical company Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB) has acquired Pennsylvania-based emerging biopharmaceutical company Quellis Biosciences Inc. in a stock-for-stock transaction, the company said.

The acquisition of Quellis was structured as a stock-for-stock transaction whereby all outstanding...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT